University of Guelph
Estrogen receptor beta as a novel target in acute myeloid leukemia
Patients with acute myeloid leukemia are faced with poor disease outcomes. Our research shows that targeting estrogen receptor beta selectively kills leukemia cells. The objective of this project is to determine how drug targeting of this receptor imparts this selective killing. The end goal of this work is to develop new drugs aimed at extending the lives of leukemia patients.